Glow Lifetech Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Glow Lifetech has been growing earnings at an average annual rate of 16.4%, while the Pharmaceuticals industry saw earnings growing at 13.1% annually. Revenues have been growing at an average rate of 155.3% per year.
Anahtar bilgiler
16.4%
Kazanç büyüme oranı
32.3%
EPS büyüme oranı
Pharmaceuticals Sektör Büyümesi | 7.3% |
Gelir büyüme oranı | 155.3% |
Özkaynak getirisi | n/a |
Net Marj | -412.7% |
Son Kazanç Güncellemesi | 30 Jun 2024 |
Yakın geçmiş performans güncellemeleri
Güncelleme yok
Recent updates
Gelir ve Gider Dağılımı
Glow Lifetech nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 0 | -1 | 1 | 0 |
31 Mar 24 | 0 | -2 | 1 | 0 |
31 Dec 23 | 0 | -2 | 1 | 0 |
30 Sep 23 | 0 | -2 | 1 | 0 |
30 Jun 23 | 0 | -2 | 1 | 0 |
31 Mar 23 | 0 | -2 | 1 | 0 |
31 Dec 22 | 0 | -2 | 1 | 0 |
30 Sep 22 | 0 | -1 | 1 | 0 |
30 Jun 22 | 0 | -1 | 1 | 0 |
31 Mar 22 | 0 | -2 | 2 | 0 |
31 Dec 21 | 0 | -11 | 5 | 0 |
30 Sep 21 | 0 | -12 | 5 | 0 |
30 Jun 21 | 0 | -13 | 5 | 0 |
31 Mar 21 | 0 | -12 | 4 | 0 |
31 Dec 20 | 0 | -1 | 1 | 0 |
30 Sep 20 | 0 | -2 | 1 | 0 |
30 Jun 20 | 0 | -1 | 1 | 0 |
31 Mar 20 | 0 | -1 | 1 | 0 |
Kaliteli Kazançlar: 9DO is currently unprofitable.
Büyüyen Kar Marjı: 9DO is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 9DO is unprofitable, but has reduced losses over the past 5 years at a rate of 16.4% per year.
Büyüme Hızlandırma: Unable to compare 9DO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: 9DO is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (28.7%).
Özkaynak Getirisi
Yüksek ROE: 9DO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.